MEDICA Trade Fair 2024
Shop
  • United States

About A1c

What is A1C?

A1C test results are reported as a percentage. A higher percentage indicates higher blood glucose levels in the past 2 to 3 months.
The A1C blood test is used to diagnose diabetes, plan your diabetes treatment, and monitor how well your treatment is working over time. (source)
A normal A1C level is below 5.7%, a level of 5.7% to 6.4% indicates prediabetes, and a level of 6.5% or more indicates diabetes. (source)

The higher the levels, the greater your risk of developing diabetes complications.

The ADA recommends that the goal for most adults with diabetes is an A1C level of less than 7%. However, there’s no one-size-fits-all target. The individual goal will depend on many things, such as your age and other medical conditions. Consult your doctor to set your own individual A1C goal. (source,source)

Unlike the glucose test, the A1C test does not require fasting before having blood drawn.

The OBM rapid A1c test allows a 5-minute A1C test at home using a fingerstick blood sample, offering laboratory-level accuracy.

Blogs

Read our most recent insights for people with diabetes and healthcare professionals.

View all blogs

Post-DTM 2024: Orange Biomed’s Key Takeaways and Future Plans

Discover Orange Biomed’s journey and innovations in diabetes technology after the Diabetes Technology Meeting 2024, focusing on health equity and solutions.

Innovations in A1C Testing: What’s Happening at the Diabetes Technology Meeting 2024

Explore innovations in A1C testing at the Diabetes Technology Meeting 2024. Learn about Orange Biomed’s OBM rapid A1c and its impact on equitable diabetes care.

ADA 84th Scientific Sessions and Post Conference Forum Recap – New POC A1C Test and Additional Innovative Solutions Unveiled

Stay Informed Ahead of the Next Diabetes Conference in 2025. The ADA’s (American Diabetes Association) 84th Scientific Sessions, held from June 21–24 in Orlando, Florida, showcased breakthrough research and discussions

Orange Biomed to Present a Revolutionary New Method of A1c Testing at ADA 2024 – Preview Before Public Release

Learn How The Microfluidic Technology In OBM rapid A1c, A New At-Home Device For Monitoring HbA1C, Can Generate Lab-Accurate Results From A Single Drop of Blood For More Accessible And

5 Important Women in STEM Making Strides in Diabetes Care and Advocacy in 2024

5 Women Making Strides in Diabetes Care and Advocacy in 2023. Women’s History Month may be over, but that…

Orange Biomed to Attend MEDICA & Diabetes Technology Meeting to Spread Awareness of A1c Testing Gaps

Seattle, WA, October 30, 2023—Orange Biomed—a healthcare startup with cutting-edge diabetes management technology—announced their attendance at major industry events: Diabetes Technology Meeting and MEDICA. Orange Biomed is a medical device

Shop
  • United States